Placebo FMT

OTHER6 trials

Conditions

Active Ulcerative ColitisEnterobacteriaceae InfectionsIdiopathic Pulmonary FibrosisMetabolic SyndromeMulti-antibiotic ResistanceObesityRenal Cell Carcinoma

Phase 1

FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae

RecruitingNCT04759001

Fondazione Policlinico Universitario Agostino Gemelli IRCCSEnterobacteriaceae Infections, Multi-antibiotic Resistance

Start: 2021-02-18End: 2026-08-15Target: 52Updated: 2026-03-19

Fecal Microbiota Transplantation to Improve Efficacy of Immune Checkpoint Inhibitors in Renal Cell Carcinoma

CompletedNCT04758507

Fondazione Policlinico Universitario Agostino Gemelli IRCCSRenal Cell Carcinoma

Start: 2021-02-18End: 2025-07-28Updated: 2025-09-08

Superdonor FMT in Patients With Ulcerative Colitis

RecruitingNCT05739864

Fondazione Policlinico Universitario Agostino Gemelli IRCCSActive Ulcerative Colitis

Start: 2023-02-13End: 2027-02-14Target: 42Updated: 2026-03-19

FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae

RecruitingNCT05791396

Fondazione Policlinico Universitario Agostino Gemelli IRCCSEnterobacteriaceae Infections, Multi-antibiotic Resistance

Start: 2024-02-08End: 2026-04-30Target: 36Updated: 2025-03-12

Phase 2

Fecal Microbial Transplantation and Fiber Supplementation in Participants With Obesity and Metabolic Syndrome.

CompletedNCT03477916

University of AlbertaMetabolic Syndrome, Obesity

Start: 2018-04-09End: 2020-12-31Updated: 2022-01-05

Unknown Phase

Faecal Microbiota Transplantation to Ameliorate Nintedanib-induced Diarrhea in Patients With Idiopathic Pulmonary Fibrosis

Not yet recruitingNCT05755308

Fondazione Policlinico Universitario Agostino Gemelli IRCCSIdiopathic Pulmonary Fibrosis

Start: 2023-10-31End: 2026-04-30Target: 114Updated: 2023-09-06

Related Papers

Fecal microbiota transplantation to improve efficacy of immune checkpoint inhibitors in renal cell carcinoma (TACITO trial).

Journal of Clinical Oncology2022-02-1610 citations

Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial.